enos polymorphisms
Recently Published Documents

TOTAL DOCUMENTS

43
(FIVE YEARS 2)

H-INDEX

8
(FIVE YEARS 0)
Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

scholarly journals Pharmacogenetic Implications of eNOS Polymorphisms (Glu298Asp, T786C, 4b/4a) in Cardiovascular Drug Therapy

In Vivo ◽  
2019 ◽  
Vol 33 (4) ◽  
pp. 1051-1058
Author(s):  
ANGELA COZMA ◽  
ADRIANA FODOR ◽  
OLGA HILDA ORASAN ◽  
ROMANA VULTURAR ◽  
DOREL SAMPLELEAN ◽  
...  
Keyword(s):  
Drug Therapy ◽  
Cardiovascular Drug ◽  
Enos Polymorphisms

scholarly journals Association of endothelial nitric oxide synthase (eNOS) polymorphisms with EGFR-mutated lung adenocarcinoma in Taiwan

2018 ◽  
Vol 9 (14) ◽  
pp. 2518-2524 ◽  
Author(s):  
Chun-Yao Huang ◽  
Ming-Ju Hsieh ◽  
Wen-Jun Wu ◽  
Whei-Ling Chiang ◽  
Tu-Chen Liu ◽  
...  
Keyword(s):  
Nitric Oxide ◽  
Nitric Oxide Synthase ◽  
Lung Adenocarcinoma ◽  
Endothelial Nitric Oxide Synthase ◽  
Oxide Synthase ◽  
Endothelial Nitric Oxide ◽  
Enos Polymorphisms ◽  
Egfr Mutated

scholarly journals IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients

Oncotarget ◽  
2017 ◽  
Vol 8 (10) ◽  
pp. 16887-16898 ◽  
Author(s):  
Mariantonietta Di Salvatore ◽  
Filippo Pietrantonio ◽  
Armando Orlandi ◽  
Marzia Del Re ◽  
Rosa Berenato ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Treatment Outcomes ◽  
Cancer Patients ◽  
Line Treatment ◽  
First Line ◽  
Colorectal Cancer Patients ◽  
Enos Polymorphisms ◽  
First Line Treatment

Prognostic value of T786C and G894T eNOS polymorphisms in sickle cell disease

Nitric Oxide ◽  
2017 ◽  
Vol 62 ◽  
pp. 17-23 ◽  
Author(s):  
Iakovos Armenis ◽  
Vassiliki Kalotychou ◽  
Revekka Tzanetea ◽  
Panagoula Kollia ◽  
Zoi Kontogeorgiou ◽  
...  
Keyword(s):  
Sickle Cell Disease ◽  
Sickle Cell ◽  
Prognostic Value ◽  
Cell Disease ◽  
Enos Polymorphisms

scholarly journals ENOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: Final results of the ePHAS Study

2016 ◽  
Vol 48 ◽  
pp. e23 ◽  
Author(s):  
A. Casadei Gardini ◽  
G. Marisi ◽  
L. Faloppi ◽  
E. Scarpi ◽  
F.G. Foschi ◽  
...  
Keyword(s):  
Clinical Outcome ◽  
Advanced Hcc ◽  
Enos Polymorphisms
Load More ...
Sign in / Sign up

Export Citation Format

Share Document